Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.

Routines to create rounded corners, with either circular rounding, or continuous curvature rounding with no sudden curvature transitions. Provides rounding of corners or rounding that preserves corner ...